CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 162 filers reported holding CLOVIS ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $39,000 | +875.0% | 3,765 | +191.6% | 0.00% | – |
| Q3 2019 | $4,000 | -55.6% | 1,291 | +109.9% | 0.00% | – |
| Q2 2019 | $9,000 | -30.8% | 615 | +15.0% | 0.00% | – |
| Q1 2019 | $13,000 | +44.4% | 535 | 0.0% | 0.00% | – |
| Q4 2018 | $9,000 | -30.8% | 535 | +25.9% | 0.00% | – |
| Q3 2018 | $13,000 | -62.9% | 425 | -43.6% | 0.00% | – |
| Q2 2018 | $35,000 | -16.7% | 753 | -6.2% | 0.00% | -100.0% |
| Q1 2018 | $42,000 | -46.2% | 803 | -29.1% | 0.00% | 0.0% |
| Q4 2017 | $78,000 | -17.0% | 1,133 | -0.7% | 0.00% | 0.0% |
| Q3 2017 | $94,000 | +14.6% | 1,141 | +31.6% | 0.00% | 0.0% |
| Q2 2017 | $82,000 | +78.3% | 867 | +22.1% | 0.00% | 0.0% |
| Q1 2017 | $46,000 | +9.5% | 710 | -25.3% | 0.00% | 0.0% |
| Q4 2016 | $42,000 | -16.0% | 950 | -31.8% | 0.00% | 0.0% |
| Q3 2016 | $50,000 | +2400.0% | 1,393 | +709.9% | 0.00% | – |
| Q2 2016 | $2,000 | – | 172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |